Apoptin-responsive pathways

Apoptin-responsive pathways refer to the specific molecular cascades activated by the Chicken Anemia Virus protein Apoptin (VP3) to induce cell death exclusively in cancer cells. The selectivity of these pathways is governed by the differential localization of Apoptin, which remains cytoplasmic in normal cells but translocates to the nucleus in transformed cells following tumor-specific phosphorylation at Thr-108 (Backendorf et al., 2008, doi:10.1016/j.febslet.2008.04.011). Once in the nucleus, Apoptin interacts with several key proteins, most notably the Anaphase-Promoting Complex/Cyclosome (APC/C) subunit Cdc27, leading to cell cycle arrest at the G2/M phase (Teodoro et al., 2004, doi:10.1101/gad.1157904). Additionally, Apoptin triggers the translocation of the orphan nuclear receptor Nur77 from the nucleus to the mitochondria, where it promotes cytochrome c release and activates the intrinsic apoptotic pathway (Maddika et al., 2005, doi:10.1038/sj.onc.1208744). These pathways are highly significant for oncology because they function independently of the p53 tumor suppressor, which is frequently mutated or lost in many human cancers (Danen-Van Oorschot et al., 1997, doi:10.1073/pnas.94.11.5843). Therapeutic strategies targeting these pathways often involve the delivery of Apoptin via viral vectors or as a cell-permeable recombinant protein, aiming to exploit the unique signaling environment of malignant cells for targeted destruction.

Other names

Apoptin signalingVP3-mediated apoptosisTumor-selective apoptotic signalingCAV VP3-induced pathways

Apoptin (VP3) selectively induces p53-independent apoptosis in tumor cells by translocating to the nucleus, inhibiting the APC/C complex to cause G2/M arrest, and inducing mitochondrial translocation of Nur77 (Backendorf et al., 2008; Teodoro et al., 2004).